Tbx1 has been implicated as a candidate gene responsible for defective pharyngeal arch remodeling in DiGeorge/Velocardiofacial syndrome. Tbx1 +/ À mice mimic aspects of the DiGeorge phenotype with variable penetrance, and null mice display severe pharyngeal hypoplasia. Here, we identify enhancer elements in the Tbx1 gene that are conserved through evolution and mediate tissue-specific expression. We describe the generation of transgenic mice that utilize these enhancer elements to direct Cre recombinase expression in endogenous Tbx1 expression domains. We use these Tbx1-Cre mice to fate map Tbx1-expressing precursors and identify broad regions of mesoderm, including early cardiac mesoderm, which are derived from Tbx1-expressing cells. We test the hypothesis that fibroblast growth factor 8 (Fgf8) functions downstream of Tbx1 by performing tissue-specific inactivation of Fgf8 using Tbx1-Cre mice. Resulting newborn mice display DiGeorge-like congenital cardiovascular defects that involve the outflow tract of the heart. Vascular smooth muscle differentiation in the great vessels is disrupted. This data is consistent with a model in which Tbx1 induces Fgf8 expression in the pharyngeal endoderm, which is subsequently required for normal cardiovascular morphogenesis and smooth muscle differentiation in the aorta and pulmonary artery. D
Introduction
The pharyngeal arches are transient embryonic structures that give rise to the ventral regions of the head and neck. The pharyngeal arches arise as ventrolateral outpouches. Each arch consists of a mesodermal core covered with an outer layer of ectoderm and an inner layer of endoderm. The arches are invaded by neural crest cells that remodel the primitive structure and form mature tissues including bone, nerve, connective tissue, and smooth muscle. The parathyroids and thymus are derived from the endoderm of the pharyngeal pouches with contributions from neural crest (Graham, 2001; Graham and Smith, 2001) . Contained within the arches are a series of initially bilaterally symmetric arteries that are remodeled to form the mature asymmetric aortic arch arteries. The formation and remodeling of the pharyngeal arches and associated arch arteries are a result of complex molecular interactions between the mesodermally derived arch core mesenchyme, ectoderm, endoderm, and neural crest cells (Hiruma et al., 2002) . Observations of pharyngeal patterning abnormalities secondary to a specific genetic mutation might reflect defects in ectoderm, mesoderm, endoderm, or neural crest. Defects may reflect a primary defect in a given tissue layer or defective signaling between tissue types.
DiGeorge syndrome is a common human haploinsufficient disorder affecting pharyngeal arch development and patterning. DiGeorge syndrome is characterized by decreased or absent parathyroid and thymus, craniofacial abnormalities, and conotruncal and aortic arch cardiac defects (Epstein, 2001; Goldmuntz and Emanuel, 1997) . The T-box transcription factor TBX1 has recently been described as a candidate gene for DiGeorge syndrome.
Targeted inactivation of Tbx1 in mice results in DiGeorgelike cardiovascular, thymic, and parathyroid defects in embryos heterozygous for the mutation. Tbx1 nulls display a more complete pharyngeal arch phenotype including severe hypoplasia of the thymus and parathyroid, craniofacial and skeletal abnormalities, and cleft palate in addition to cardiovascular malformations (Jerome and Papaioannou, 2001; Lindsay et al., 2001; Merscher et al., 2001) .
Tbx1 is a member of the T-box family of transcription factors. The expression pattern of Tbx1 is consistent with a role in pharyngeal arch and pouch remodeling (Garvey et al., 1996) . As the pharyngeal arches are forming between E9 and 11 in the mouse, Tbx1 is expressed in the head mesenchyme and mesenchyme dorsal to the pharynx as well as the mesenchymal cores of pharyngeal arches 1 -3. Tbx1 is expressed in the epithelium of the otic vesicle and in the epithelium of the endodermal pouches (Garvey et al., 1996) . Endodermal expression in the pharyngeal pouches is temporally regulated such that expression is first noted in pouch 1, followed by sequential expression in more caudal pouches (Vitelli et al., 2002a) . Expression is also observed in the sclerotome of the developing somite, consistent with the skeletal defects seen in Tbx1 null mice (Jerome and Papaioannou, 2001) .
Tbx1 affects developmental processes in both cell autonomous and cell nonautonomous fashions. This bimodal activity of Tbx1 is evident in the phenotype of DiGeorge syndrome and in targeted Tbx1 mice. In the pharyngeal endoderm, Tbx1 is presumed to act cell autonomously to directly regulate the development of the thymic and parathyroid precursor cells in which it is expressed (Jerome and Papaioannou, 2001; Merscher et al., 2001) . The function of Tbx1 in regulating development of other pharyngeal structures has been less clear. While Tbx1 is broadly expressed in mesodermal tissues including the head mesenchyme and the mesenchymal cores of the pharyngeal arches, these areas are heavily invested with and remodeled by neural crest cells that give rise to the bulk of the mature structures (Graham, 2001; Graham and Smith, 2001) . Results from our lab and others have shown that Tbx1 is not expressed in the neural tube or neural crest cells (Kochilas et al., 2002; Vitelli et al., 2002a) . Thus, a primary role of Tbx1 in pharyngeal development may be to regulate expression of secreted signaling factors required for migration, differentiation, and maintenance of neural crest cells.
Recent reports have suggested that Tbx1 expression in pharyngeal pouch endoderm regulates expression of secreted Fgf8 (Abu-Issa et al., 2002; Frank et al., 2002; Kochilas et al., 2002; Vitelli et al., 2002b) . In Tbx1 nulls, Fgf8 is down-regulated in Tbx1 expression domains such as the pharyngeal endoderm, while Fgf8 expression is unaltered in surface ectoderm that does not normally express Tbx1. Fgf8 hypomorphic mice display defects in aortic arch patterning similar to those seen in Tbx1-deficient animals. Defective aortic arch patterning in the Fgf8 hypomorphs may be due to inappropriate cell death or differentiation of the invading neural crest cells caused by a loss of Fgf8 from the underlying endoderm (Abu-Issa et al., 2002 and Frank et al., 2002) . It remains unclear whether Fgfs have direct longrange effects on cardiac neural crest cells, or if they activate secondary signaling cascades within the pharyngeal mesenchyme, which subsequently signal to the neural crest. Patterning of mesenchyme by an adjacent layer of epithelium is a common mechanism utilized in the formation of many tissues throughout embryogenesis (Johnson et al., 1994) .
To better understand the role of Tbx1 and downstream signaling pathways in aortic arch patterning, we have analyzed the cis-control elements regulating Tbx1 gene expression in murine embryos and we have identified separable regions regulating gene expression. We have utilized Tbx1 regulatory elements to generate transgenic mice expressing Cre-recombinase in the Tbx1 expression domain. Fate-mapping studies utilizing these mice provide new insights into the extent of the contributions of cells of the Tbx1 lineage to mature structures. We demonstrate that targeted inactivation of Fgf8 in the Tbx1 domains results in a spectrum of cardiovascular defects reminiscent of DiGeorge syndrome, confirming a role for Fgf8 in cardiovascular patterning, demonstrating that FGF8 production fromTbx1 expressing cells is required for normal cardiovascular patterning.
Materials and methods

Transgenic analysis
Tbx1 cDNA sequences were used to identify human and mouse genomic sequences in the NCBI database. Regions of sequence homology were identified by direct humanmouse sequence comparison. Fragments were amplified by PCR from SV129 mouse genomic DNA using LA-Taq DNA polymerase (TAKARA). Fragments were subcloned into a modified pBluescript vector containing a lacZcoding region and SV40 poly A using a subcloning strategy in which the 5V primer incorporated XhoI and BamHI restriction sites while the 3V primer incorporated a BglII site. Fragments are defined in Fig. 1 (Fig. 1A) .
Enhancer-lacZ constructs were purified by restriction digestion and gel purification. Pronuclear injections for generation of transgenic animals were performed by the University of Pennsylvania mouse transgenic core or the Cardiology Division mouse transgenic core. Expression patterns were assayed following overnight incubation in X-gal (5V -bromo-4-chloro-3-indolyl-h-D-galactopyranoside). Protocols are available online at http://www.uphs.upenn. edu/mcrc. To establish stable lines, the 7.6-kb Tbx1 sequence used to produce Tbx1-lacZ construct A (Fig. 1B) was subcloned into either lacZ or Cre-recombinase expression vectors.
Generation of Tbx1-CreDR26R embryos
To lineage trace Tbx1-Cre expressing cells, potential Tbx1-Cre founders were identified by PCR and mated to homozygous R26R reporter mice (Soriano, 1999) . Embryonic day 0.5 was defined as noon on the day of vagina plug. Six independent Tbx1-Cre founders exhibit identical staining patterns consistent with the known expression domain of Tbx1. Embryos were fixed in 2% PFA for 2 h and stained for h-galactosidase activity at 37jC. Images presented are representative of data obtained for all founders.
Generation of Tbx1-CreDFgf 8 flox/À embryos
To generate Tbx1-domain tissue specific deletion of Fgf8, we utilized an allelic series of targeted mutations at the Fgf8 gene locus (Meyers et al., 1998) . One parent in the mating is homozygous for an Fgf8 allele in which exons 4 and 5 are flanked by loxP sites (Fgf8 flox/flox ). The Fgf8 null allele was generated by germline Cre-recombinase-mediated excision of exons 4 and 5 from the loxP allele. Fgf8 heterozygotes were mated to Tbx1-Cre founders to generate Tbx1-CreDFgf8 +/ À . Pups from appropriate intercrosses were harvested between 9.5 and 18.5 dpc or at birth and fixed 24 -48 h in 4% paraformaldehyde.
Immunohistochemistry and histology
Stained and unstained tissues or embryos were dehydrated through graded alcohol series, embedded in paraffin, and sectioned at 6-10 AM. Sections from embryos stained for h-galactosidase expression were counterstained with eosin. Neonatal heart-lung sections from Tbx1-CreD Fgf8 flox/ À embryos were stained with hemotoxylin and eosin to a-actin expression (http://www.uphs.upenn.edu/ mcrc). In situ hybridization was performed as described (Wawersik and Epstein, 2000) .
Genotyping
Genotyping was performed by PCR on DNA obtained from embryonic membranes or embryo tails. Primers, PCR conditions and genotyping protocols are available online at http://www.uphs.upenn.edu/mcrc.
Results
Identification of conserved regions in the Tbx1 upstream genomic region between human and mouse
Traditional enhancer analysis requires subcloning of large segments of genomic DNA and an iterative deletion scheme to identify individual enhancer regions. We chose instead to take advantage of the power of multispecies comparative sequence analysis to identify noncoding regions of homology. Using standard database techniques, we compared approximately 20 kb of DNA sequence upstream from the Tbx1 start methionine between human and mouse by NCBI Blast2 (Altschul et al., 1997) . We identified more than 10 regions of homology that ranged in size from approximately 50-250 bp (Fig. 1A) . To assess the potential in vivo function of these elements, we cloned genomic fragments containing regions of conservation upstream of a lacZ reporter gene (Fig. 1B) and made F0 transient transgenic mice. These homologous regions were grouped to facilitate PCR based cloning of only four genomic fragments (Fig. 1A ). Subsequent analysis of the same sequences with the VISTA sequence comparison program confirmed our original analysis and identified additional regions of somewhat lesser homology that were not included in our transgenic analysis ( Fig. 1A) Mayor et al., 2000) . Comparative sequence analysis allowed us to eliminate nearly two thirds of the 20 kb of DNA examined before generating any transgenic animals Mayor et al., 2000) .
Within the proximal 3.1 kb of sequence upstream of the start ATG of Tbx1, significant regions are conserved between mouse and human; this region contains the minimal promoter and transcriptional start site(s) (Fig. 1B) . However, this region was insufficient to direct expression of lacZ in eight transient transgenic embryos (Fig. 1, construct H) . However, addition of three distinct regions that together contained most of the regions of significant homology within the proximal 16 kb of upstream sequence (Figs. 1A,B, construct A) was sufficient to recapitulate the endog- enous expression domain of Tbx1 (Fig. 2) . In two independently derived embryos, and in two subsequently developed stable transgenic lines, expression was evident in the head mesenchyme ( Figs. 2A -D) , the posterior region of the otic vesicle epithelium (Fig. 2C ), the sclerotome (Figs. 2A -C), and pharyngeal endoderm (Fig. 2D) . Expression was present in the core mesenchyme of the pharyngeal arches and in a subpopulation of myocardial cells in the heart (Figs. 2B,C). Each of these domains of expression represents endogenous regions of Tbx1 expression as demonstrated by our laboratory (Figs. 2E,F) and others (Garg et al., 2001; Garvey et al., 1996) . Hence, critical sequences required for most or all of Tbx1 expression reside within regions of upstream homology (fragments 1 -3, Fig. 1 ).
We constructed serial deletions of the 7.6-kb transgenic expression construct A by removing regions of sequence homology, as outlined in Fig. 1 . Removal of the most upstream region (fragment 1, resulting in construct F, Fig.  1B ) results in the complete loss of all expression at E10.5 (14 genotype positive embryos examined). Similarly, constructs containing only fragment 3 and the proximal element (construct G, Fig. 1B ) failed to drive transgene expression in 10 transgenic embryos. A 207-bp element at the 5V end of fragment 1 is sufficient to drive reporter expression in the somite (construct B, and Fig. 3A) . Deletion of this somite element from construct A (producing construct C) eliminates somite expression but leaves other expression domains unaffected, thus demonstrating that this element is necessary and sufficient for somite expression (Fig. 3B) . Somitic expression of Tbx1-lacZ was evident in the myotomal region of the somite, but not in the epithelial layer (Fig.  3C ). Expression in myotomal cells was confirmed by costaining with a myoD antibody (Figs. 3D,E) and with an antibody to myosin (MF20, not shown).
Transgenic construct D, which utilizes only Fragment 1 attached to the Tbx1 proximal element, recapitulates the entire Tbx1 expression domain. This was also the case when Fragment 1 was attached to a heterologous HSP promoter (construct E). Thus, all of the sequences required for regulation of Tbx1 expression are contained within the 3.5-kb Fragment 1. Previous reports have demonstrated that Tbx1 expression in pharyngeal mesenchyme and endoderm is genetically downstream of Sonic hedgehog (Shh) signaling (Garg et al., 2001) . Consistent with these results, we observed down-regulation of Tbx1 transgene expression in Shh null embryos (Chiang et al., 1996) and ectopic Tbx1 expression in the periotic mesenchyme in a model of Shh overexpression (ShhP1) (Riccomagno et al., 2002 ) (data not shown). Shh may activate Tbx1 indirectly by inducing expression of forkhead transcription factors (Yamagishi et al., 2003) . A recent report demonstrated that sequences containing forkhead transcription factor binding sites, located at the 3Vend of our Fragment 1 (Fig. 1B) , are responsible for expression in head mesenchyme and pharyngeal endoderm (but not pharyngeal mesoderm) (Yamagishi et al., 2003) . Our results are consistent with this observation, although we have not yet directly confirmed the importance of the reported forkhead-binding site. Specific sequences required for expression in pharyngeal mesoderm and otic vesicle, while contained within Fragment 1, remain to be elucidated.
Characterization of transgenic mice expressing Cre recombinase in the Tbx1 expression domain and fate-mapping of Tbx1 descendents
We used the Tbx1 regulatory regions to create transgenic mice expressing Cre recombinase in Tbx1 expression domains. We included all of the conserved regions depicted in Fig. 1B construct A. A total of six independent Creexpressing transgenic lines were expanded and characterized. All six lines yielded consistent results, suggesting faithful expression of Tbx1-Cre in endogenous domains, unrelated to the site of transgene insertion. We refer to these as Tbx1-Cre mice.
We crossed Tbx1-Cre mice with R26R reporter mice that express lacZ constitutively in cells that express Cre recombinase (Soriano, 1999) . Hence, the descendents of Creexpressing cells can be identified by assaying for hgalactosidase activity even after Cre expression has itself subsided. We examined Tbx1-CreDR26R embryos between E7.5 and birth (Fig. 4) . Unexpectedly, at E7.5, we observed labeled cells in a pattern similar to the cardiac crescent where myocardial cells arise (Fig. 4A) . By E8.5, labeled cells were identified in the pharyngeal region and head mesenchyme (Fig. 4B ) though the heart tube was unlabeled. By E9.0 -E9.5, h-galactosidase-expressing cells were seen in the outflow tract of the heart and the primordial of the right ventricle, but labeled cells were not seen in the left ventricle (Figs. 4C -E) . Tbx1 previously has been shown to be expressed by a few cardiac myocytes in the outflow tract of the heart (Vitelli et al., 2002a) , and we observed a similar expression pattern in our Tbx1-lacZ embryos, but many cardiac myocytes in the heart at E9.5 do not express Tbx1. This indicates that cardiac myocytes in the outflow tract and right ventricle derive from Tbx1-expressing precursors that have subsequently extinguished Tbx1 expression.
By E10.5, a few labeled cells were seen crossing the interventricular sulcus (arrow, Fig. 4G ) and significant portions of the left ventricle were labeled by E14.5 (Fig.  4H ) and in the adult heart (Fig. 4I ) in addition to almost the entire right ventricle. Throughout development, labeled cells were also identified in pharyngeal endoderm and derivatives including the thymus (not shown). The pattern of expression during development of the heart, shown in Fig. 4 , is consistent with expression of Tbx1 by progenitors of the recently described secondary (or anterior) heart field (Kelly and Buckingham, 2002; Kelly et al., 2001; Waldo et al., 2001) .
We examined Tbx1 gene expression by in situ hybridization at E7.5 (Fig. 5A ) and E8.5 (Fig. 5C ). At E7.5, Tbx1 expression is evident in broad regions of the lateral plate mesoderm including cardiogenic regions (Fig. 5A) . Expression partially overlaps with that of Nkx2.5, an early marker of cardiogenic cells (Fig. 5B ). Tbx1 appears to be expressed in a subset of cardiogenic precursors, consistent with our Tbx1-Cre fate-mapping experiments. By E8.5, endogenousTbx1 expression (Fig. 5C ) is weak in the heart region, while Nkx2.5 is abundantly expressed in the myocardium (Fig. 5D ). To confirm that our Tbx1-Cre mice were expressing Cre recombinase is the same progenitors as those that express Tbx1, we performed in situ hybridization using adjacent sections from an E7.25 Tbx1-Cre embryo with Tbx1 and Cre riboprobes (Figs. 5E,F) . Expression of Tbx1 and Cre were evident in the same population of early mesoderm, indicating that Cre expression accurately recapitulates endogenous expression of Tbx1 in this tissue. Taken together, these results indicate that Tbx1 is expressed very early and transiently in some cardiac progenitors that later give rise to the outflow tract myocardium, large portions of the right ventricle, and some portions of the left ventricle.
A subpopulation of vascular smooth muscle is derived from Tbx1-expressing cells
In all of the Tbx1-Cre adult mice examined, we noted broad expression in the vasculature. Histological sections indicated that some vascular smooth muscle is derived from Tbx1-Cre expressing cells (Fig. 4I, inset) . Interestingly, labeled smooth muscle was seen in the great vessels including the ascending aorta and the descending aorta beyond the ductus arteriosus. However, the aortic arch and the carotid arteries were not labeled (Fig. 4I) . We have previously shown that smooth muscle in the aortic arch and carotid arteries derives from neural crest (Li et al., 2000) . Hence, vascular smooth muscle is derived from lateral plate mesoderm, identified by Tbx1-Cre expression, and also from neural crest, identified by Wnt1-Cre (Jiang et al., 2000) and Pax3-Cre expression (Li et al., 2000) . Taken together, these results suggest that Tbx1 may play early roles in cardiac and smooth muscle development.
Targeted inactivation of Fgf8 in Tbx1 expression domains
Fgf8 signaling has recently been reported as a critical mediator of aortic arch development downstream of Tbx1 .5, expression of h-galactosidase is evident in the area of the cardiac crescent (cc) in Tbx1-CreDR26R embryos. (B) At E8.5, expression is strong in the head mesenchyme but little expression is seen in the heart (ht). (C) At E9.0, expression is evident in the head mesenchyme, otic vesicle, and pharyngeal arch mesenchyme. Expression is also seen in the outflow tract of the heart. (D) By E9.5, expression has extended into the right ventricle. (E) Higher magnification of an E9.5 heart demonstrates restriction of blue cells to the right ventricle (rv) and conotruncus. (F) Right lateral view of an embryo at E10.5 showing strong expression in head mesenchyme and heart. Expression in the right atria is weak and spotty. (G) Left lateral high magnification view of the heart of the embryo in F. Strong expression is observed in the right ventricle and patches of expressing cells (white arrowhead) can be observed crossing the interventricular boundary into the left ventricle (lv). (H) At E14.5, the right ventricle appears to be almost completely derived from Tbx1 descendants. Staining crosses the boundary between the right and left ventricles (dotted line) and significant regions of the left ventricle are stained. (I) Staining of the heart from an adult Tbx1-CreDR26R mouse reveals extensive contribution from Cre-expressing progenitors throughout the myocardium with more extensive contribution to the right ventricle and atria compared with the left ventricle. h-galactosidase expression is detected in the ascending aorta (AAo) and descending aorta (DAo) but is absent from the aortic arch (between red arrowheads), the right common carotid (RCC), and left common carotid (LCC) arteries. A section through the descending aorta stained for smooth muscle a-actin (brown) demonstrates coexpression of this smooth muscle marker with hgalactosidase (I inset). (Abu-Issa et al., 2002; Frank et al., 2002; Vitelli et al., 2002b) . To perform tissue specific inactivation of Fgf8 in the Tbx1 expression domain, we took advantage of previously described Fgf8 null (Fgf8
) and loxP (Fgf8 flox ) alleles (Meyers et al., 1998) . In the loxP allele, Fgf8 exons 4 and 5 are flanked by loxP sites. Cre-recombinase mediated excision generates a null allele in Cre-expressing tissues. Mice heterozygous for the Fgf8 null allele were mated to Tbx1-Cre founders to generate compound heterozygotes (Tbx1-CreDFgf8 +/ À ). Tbx1-CreDFgf8 +/ À mice were mated to mice homozygous for an Fgf8 loxP flanked allele (Fgf8 flox/flox ). One quarter of the progeny from this mating are expected to be Tbx1-CreDFgf8 flox/ À . Following Cremediated recombination at the loxP sites, these embryos are Fgf8 null in the Tbx1-Cre expression domain.
To confirm specific loss of Fgf8 signal in the Tbx1 expression domain, we performed radioactive in situ hybridization on E10.5 wild type and Tbx1-CreDFgf8 flox/ À embryo sections. Fgf8 signal is greatly reduced in pharyngeal endoderm of Tbx1-CreDFgf8 flox/ À embryos (Fig. 6B  arrows, en) compared to a wild-type littermate (Fig. 6A) . Fgf8 expression is unaffected in the first arch ectoderm where Tbx1 is not expressed (Figs. 6A ,B white arrowhead, ec). These results confirm that Tbx1-Cre is functional within the normal Tbx1 expression domain, and that loss of Fgf8 signal is tissue-specific.
We examined litters derived from Tbx1-CreDFgf8
and Fgf8 flox/flox crosses between E9.5 and birth. Between E9.5 and E15.5, we found the expected number of Tbx1-CreDFgf8 flox/ À embryos (27/115, 23.5%). By E18.5, we found an occasional nonviable Tbx1-CreDFgf8 flox/ À embryo, and at birth we identified numerous cyanotic Tbx1-CreDFgf8 flox/ À pups with irregular gasping breathing patterns that succumbed shortly after birth. At P1, we identified Fig. 5 . Early cardiogenic expression of Tbx1. Tbx1 expression was assessed by radioactive in situ hybridization at E7.5 (A) and E8.5 (C). Tbx1 is expressed in the cardiac crescent (cc) at E7.5 (A), but expression is down-regulated in the heart tube (ht) at E8.5 (C). Early expression is also noted in the head mesenchyme (red arrows A). Nkx2.5 is expressed in the cardiac crescent at E7.5 (B) and expression persists in the heart tube (ht) and foregut (fg) at E8.5 (D). Adjacent sections (E, F) of an E7.25 Tbx1-Cre embryo reveals expression of Tbx1 (E) and Cre (F) in a subdomain of early mesoderm (arrows, E, F).
only 11 viable Tbx1-CreDFgf8 flox/ À pups of 118 genotypes (9% vs. 25% expected) indicating significant peri-natal lethality. Additionally, Tbx1-CreDFgf8 flox/ À pups were distinguishable following thoracotomy by reduced and/or single lobed thymus. Reduced thymus is also seen in Fgf8 hypomorphs and is consistent with removal of Fgf8 in the pharyngeal endoderm. However, the gross Tbx1-CreD Fgf8 flox/ À phenotype was distinct from Fgf8 hypomorphs, which display craniofacial defects (Abu-Issa et al., 2002; Frank et al., 2002) , and from Fgf8 nulls, which are early embryonic lethal (Meyers et al., 1998) .
Tbx1-CreDFgf8 flox/ À embryos and newborn pups displayed cardiovascular patterning defects involving the outflow tract and proximal great vessels. These defects included malformations consistent with persistent truncus arteriosus, double outlet right ventricle, transposition of the great arteries, Tetrology of Fallot, atrial and ventricular septal defects and duplicated internal carotid arteries. Importantly, however, we never observed interruption of the aortic arch, right-sided aortic arch, or retro-esophageal right subclavian artery. This class of cardiovascular defect involves predominantly the aortic arch arteries without affecting the outflow tract of the heart, and are commonly seen in Tbx1 + / À embryos, Fgf8 hypomorphs, and in DiGeorge syndrome. Hence, inactivation of Fgf8 in the Tbx1 expression domain recapitulates some, but not all, of the cardiovascular defects related to Tbx1 deficiency.
Normal great vessel morphology is displayed in Fig. 7A . The aorta (Ao) is dorsal to the pulmonary artery and the proximal arch elevates to the right. Cardiovascular defects observed in Tbx1-CreDFgf8 flox/ À animals include defects of conotruncal septation and malpositioning of the proximal great vessels. An example of malrotation of the great arteries is shown in Fig. 7B . In this animal, the aorta is positioned ventrally in a side-by-side presentation with the pulmonary artery (PA). The pulmonary artery overrides the left ventricle (Fig. 7F) . Another Tbx1-CreDFgf8 flox/ À animal presented with transposition (Fig. 7C) . In this individual, the aorta is ventral to the pulmonary artery (Fig. 7C) . Hemotoxylin and eosin (H&E) staining of sections confirms an inappropriate ventral position of the aorta, and demonstrates that the aorta is in continuity with both ventricles through a large aortico-pulmonary window (AP, Fig. 7G ). Several Tbx1-CreDFgf8 flox/ À pups presented with atrial septal defects (ASD, Fig. 7I ) and membranous ventricular septal defects (VSD, Fig. 7J ). One severely affected animal presented with a Tetrology of Fallot-like phenotype (Figs.  7D,H) . This pup had a VSD and severe pulmonary atresia with no apparent pulmonary trunk arising from the right ventricle. The pulmonary arteries arose retrograde from the ductus arteriosus (DA-PA, Fig. 7D ). This animal also exhibited a large arterial dissection filled with thrombus ( Fig. 7H black arrows and Fig. 7L asterisk) . The dissection can clearly be seen in Panel 7L underlying the endothelial layer that lines the aortic lumen.
Aortic dissection suggests a weakness of the arterial wall. H&E staining revealed morphological abnormalities of the arterial wall in Tbx1-CreDFgf8 flox/ À mice (black arrows, Fig. 7L ) compared to wild type (Fig. 7K) . The muscular wall was of variable thickness and lacked the striated structural appearance of normal arterial smooth muscle. This observation was confirmed by smooth muscle a-actin staining (SMA). Some smooth muscle staining is observed in the aortic wall of affected individuals (Fig. 7N) . However, SMA expression is not observed in the stereotypic striated layers expected for mature arterial smooth muscle as seen in wild-type aorta (Fig. 7M) . Defective smooth muscle differentiation was a consistent finding in most Tbx1- CreDFgf8 flox/ À animals. Unexpectedly, defective smooth muscle differentiation is also observed in the esophagus (Figs. 7O,P) . SMA expression is greatly reduced (Fig. 7P ) compared to wild type (Fig. 7O) , though mesenchymal appearing cells are present.
Discussion
Tbx1 and Fgf8 in cardiovascular development
A growing body of data has implicated roles for both Tbx1 and Fgf8 during cardiac outflow tract development and aortic arch remodeling. Mutations in either gene can result in similar cardiovascular phenotypes, and compound heterozygotes have more severe defects than either heterozygote alone (Vitelli et al., 2002b) . Both Fgf8 and Fgf10 expression levels are decreased in Tbx1-deficient embryos, suggesting that Fgf signaling functions downstream of Tbx1 (Frank et al., 2002; Vitelli et al., 2002b) . Here, we provide direct evidence that inactivation of Fgf8 in Tbx1-expressing cells results in DiGeorge-like cardiovascular defects. These abnormalities are associated with a striking defect in smooth muscle differentiation. Arterial smooth muscle is derived from different embryonic origins. Smooth muscle of the aortic arch and ductus arteriosus is derived from neural crest cells (Jiang et al., 2000; Li et al., 2000) . Smooth muscle of the proximal aorta, pulmonary trunk, and descending aorta are mesodermally derived. Interestingly, defects present in our Tbx1-CreDFgf8 flox/ À embryos are not restricted to the neural crest-derived portions of the aortic arch. This indicates that smooth muscle differentiation in the aortic arches is dependent on the source and proximity of Fgf8 expression. Our results argue that endodermal Fgf8 expression is required for smooth muscle differentiation in proximal aorta and pulmonary trunk. Due to the absence of aortic arch interruptions, which are present in Fgf8 hypomorphs (AbuIssa et al., 2002) , we propose that Fgf8 produced from a non-Tbx1-regulated site, such as the ectoderm, may play a larger role in the differentiation and maintenance of smooth muscle populations within the arch proper. Additionally, we observed an unexpected decrease in smooth muscle differentiation in the esophagus. These observations suggest that Fgf8 signaling plays a crucial role in the differentiation of a broad range of pharyngeal smooth muscle. Further analysis will provide insight into the role of Fgf8 signaling in the maintenance and differentiation of smooth muscle in diverse tissues and of diverse embryonic origins.
Haploinsufficiency of Tbx1 results in cardiovascular defects that include septation outflow tract defects as well as interruptions of the aortic arch and other abnormalities related to inappropriate regression of aortic arch segments. Similar malformations are seen in Fgf8 hypomorphic mutant mice. Strikingly, however, we did not observe interruptions of the aortic arch in our Tbx1-CreDFgf8 flox/ À mice. Thus, interruptions of the aortic arch in Fgf8 hypomorphic mice may be due to deficient Fgf8 signaling that derives from tissues that do not express Tbx1. Consistent with this idea, recent results suggest that inactivation of Fgf8 in pharyngeal ectoderm results in aortic arch interruptions but not outflow tract defects (Macatee et al., 2003) . Aortic arch defects present in Tbx1 + / À mice may be caused by an unrelated mechanism, perhaps involving Fgf10 or other signaling pathways.
Tbx1 and the secondary heart field Fate-mapping studies described here using Tbx1-Cre mice indicate that this transgene is expressed by early mesodermal derivatives in the lateral and intermediate plate, including precursors of cardiac and smooth muscle. Somitic derivatives, including skeletal muscle, also derive from Creexpressing precursors in these studies (not shown). In situ expression analysis of endogenous Tbx1 is consistent with early expression in these tissues followed by rapid restriction to more precise cell populations early during gestation. Early expression in a broad range of mesodermal progenitors has not been previously suggested, though persistent expression in a small population of cardiac myocytes in the outflow tract has been reported (Vitelli et al., 2002a) . Other members of the T-box family are expressed in early mesoderm, suggesting the likelihood of functional redundancy (Garvey et al., 1996) . For instance, T (brachyury) is one of the earliest markers of mesoderm and is expressed by all early mesodermal cell types (Wilson et al., 1995) . Tbx5 is expressed by cardiogenic precursors and mutations in TBX5 cause Holt -Oram syndrome, which includes cardiac malformations (Li et al., 1997) . It is interesting to note that while Tbx1 and Tbx5 expression domains appear to overlap in early cardiogenic mesoderm, the expression domains in the heart at later time points are reciprocal (Bruneau et al., 1999) . Tbx5 is expressed in the left ventricle and atria from the looped heart tube stage onward while our results indicate Tbx1 progeny are predominantly restricted to the right ventricle (Bruneau et al., 1999) . It will be interesting to determine if Tbx1 serves overlapping and/or redundant functions with other T-box family members during early mesoderm differentiation, and how these functions may change in the specification of cardiac cell fates later in development.
We were surprised by the pattern and extent of cardiac myocyte derivation from Tbx1-expressing precursors. At the cardiac crescent stage, we identified Tbx1-Cre derived cells in the region of cardiomyogenic precursors, and Tbx1 expression itself partially overlapped with that of Nkx2.5. Shortly thereafter, Tbx1-Cre-derived cells populated the pharyngeal region, the outflow tract of the heart, and subsequently the right ventricle. This pattern of expression is highly reminiscent of the recently described secondary or anterior heart field (Kelly and Buckingham, 2002; Kelly et al., 2001; Waldo et al., 2001 ). All or most cardiac myocytes had been thought to arise from the primary heart field, which is identified by early expression of Nkx2.5 and other early cardiac markers. However, recent data suggests that portions of the outflow tract and right ventricle may arise from a secondary field located more anteriorly. The extent of contribution of this secondary heart field to the mature heart remains controversial, and may vary between species. Our data suggests that the secondary heart field may be identified by expression of Tbx1 and may originate near the cardiac crescent. The extent of contribution to the mature heart could depend on the precise markers used to differentiate the two heart fields within a region that initially represents a continuum of adjacent tissue. Hence, at the cardiac crescent stage, Nkx2.5 may label both heart fields, while Tbx1 is predominantly restricted to a subpopulation of precursors destined to be the secondary heart field.
Our results would argue for a significant contribution of Tbx1-expressing precursors to both the right and left ventricles. Intriguingly, the contribution of Tbx1 progeny to the myocardium appears to increase as the heart develops. This increase in myocardial chimerism as cardiac development proceeds may reflect displacement of cells from the primary heart field by cells of the secondary heart field. This would imply a much more invasive role for cells of the secondary heart field than has been previously noted. Labeled cells appear in the left ventricular myocardium after it is formed and are not simply added to the heart sequentially from a population of pharyngeal mesoderm. Alternatively, the early heart may be chimeric at an undetectable level, and apparent increases in chimerism over time is therefore due to clonal expansion of individual cells of different embryonic origin. Given the early mesodermal expression of Tbx1 and its later expression in pharyngeal tissues, it will be of interest to determine which cardiac precursor populations express Tbx1 and if it plays a functional role in cardiac muscle maturation. In this regard, it is noteworthy that some mouse models of DiGeorge syndrome have a thinned and poorly developed myocardium (Merscher et al., 2001) . Hence, some aspects of the Tbx1-deficient phenotype and DiGeorge syndrome could be related to a cell-autonomous role of Tbx1 in cardiac and other mesodermal progenitors.
Tbx1 and DiGeorge syndrome
Although TBX1 is an attractive candidate gene for cardiovascular defects in DiGeorge syndrome, no missense mutations have been discovered in patients with congenital heart disease or DiGeorge syndrome who do not have deletions on 22q11 (Han et al., 2001) . If TBX1 deficiency alone is responsible for cardiovascular malformations in this syndrome, it is surprising that mutations in the coding region have not been identified. It is possible that deletion of small regions on chromosome 22 results in inactivation of TBX1 in addition to another gene that contributes to the phenotype or compensates for otherwise lethal effects of TBX1 mutation (Guris et al., 2001; Yamagishi et al., 1999) . If so, hypomorphic mutations in TBX1 will possibly be associated with congenital cardiac disorders. Additionally, both over-and under-expression of Tbx1 in mice results in cardiovascular malformations (Merscher et al., 2001 ). Mutations within specific regulatory regions might reduce, or expand, TBX1 gene expression in critical tissues resulting in developmental defects in the absence of coding mutations. Therefore, it is noteworthy that the enhancer regions that we have identified are generally conserved between mouse and human. It will be of interest to determine if mutations in these regulatory regions are found in human cases of nondeleted DiGeorge syndrome or in other cases of congenital heart disease.
The observation that inactivation of Fgf8 in the Tbx1 expression domain recapitulates some, but not all, of the cardiovascular manifestations of DiGeorge syndrome is consistent with a role for Fgf8 downstream of Tbx1. This interpretation is supported by prior data that indicates downregulation of Fgf8 in embryos lacking Tbx1, but additional studies will be required to determine if Fgf8 is a direct downstream transcriptional target of Tbx1. However, our data suggests that additional targets of Tbx1 must also function during cardiovascular development since some characteristic malformations, including interruptions of the aortic arch, were not seen in our studies. Likewise, the presence of a complete array of DiGeorge-like cardiovascular malformations in Fgf8 hypomorphs, which are not recapitulated entirely by tissue-specific inactivation of Fgf8 in Tbx1-expressing cells, indicates that there are mechanisms unrelated to Tbx1 function that can result in the DiGeorge cardiovascular phenotype.
